Loading...
Loading...

Lab Automation · High-Throughput Workcells · Data Foundry · CMC Scale-Up
Automation that accelerates scientific delivery starts with process fluency. I take the same control narratives used in CMC scale-up and validation — CPPs, interlocks, sampling plans, fail-safe states — and make them executable on hardware: PLC logic on skids, deck protocols on liquid handlers, and structured payloads into LIMS/ELN and data foundry pipelines.
Convert unit-operation and safety requirements into Ladder Logic / Structured Text sequences that operators and CQV teams can verify — industrial skids and precision lab controllers alike.
Design and troubleshoot hardware interlocks, I/O maps, sensor networks, and edge relays so physical failure modes fail safe before software ever sees a happy path.
Connect PLCs and liquid handlers to LIMS/ELN sample tracking and automated data pipelines so continuous data connectivity is part of the method, not a spreadsheet afterthought.
I pair CMC and automation depth with a delivery system that keeps programs on track across external partners and internal workcells—clear decision cadence, measurable performance, inspection-ready documentation, and control logic that matches the process on the floor.
Lifecycle ownership across decide/select/transfer/manage/exit with crisp responsibilities and escalation paths.
KPI reporting, schedule risk visibility, and a predictable operating rhythm for Joint Project Teams.
Document control patterns: storage, archival, retention, access, and evidence-first readiness.
Risk registers, issue logs, decision logs, and mitigation tracking tied to program milestones.
I run risk-based validation as a connected lifecycle, not a box-checking exercise. Stage 1 design and characterization on qualified scaled-down models, Stage 2 performance qualification (PPQ), and Stage 3 continued process verification (CPV) — but the value is in how the stages link. FMEA criticality feeds the CPP/CQA control strategy, and statistically grounded sampling plans (tolerance intervals, capability targets, and power-based lot counts) make PPQ outcomes predictable before a single conformance lot runs.
That same lifecycle thinking extends into lab and process automation: recipe steps, hardware interlocks, and data lineage are treated as part of the control strategy — with models and tools (this platform included) that accelerate characterization, trending, and documentation without compromising GxP discipline.
Alongside deep drug substance experience, I bring strong drug product capabilities spanning sterile process design, aseptic fill-finish operations, lyophilization, and formulation—with hands-on execution across clinical and commercial scales.
Vial and syringe filling on automated lines (Bosch Syntegon, Vanrx), media fills, smoke studies, environmental monitoring, and pressure cascade controls within RABS/isolator and ISO 5/7 cleanroom environments.
Freeze-drying cycle development and optimization, sterile filtration and bioburden control for drug product, formulation characterization, and stability assessment for biologics including mAb, ADC, and peptide modalities.
Full-lifecycle ownership of facility and equipment build-outs: URS authoring, design review, procurement, FAT/SAT, installation, commissioning, IQ/OQ/PQ, and operational turnover. Track record on $100M+ in combined projects.
Commissioning, qualification, and validation of filling lines, RABS/isolators, lyophilizers, BSCs, CIP/SIP systems, and formulation skids. Authored and approved validation protocols and reports to cGMP standards.
Bosch Syntegon RABS
Due diligence on commercial-scale RABS design with CDMOs/EPCs; reviewed RC/CAPAs; ensured cGMP/FDA/EMA alignment for mAb and ADC drug product.
GMP Suites & Vanrx Lines
Adapted clinical cGMP production suites to new platforms; authored equipment URS; evaluated and procured 10+ Vanrx fill lines and RABS systems.
ISO 5 RABS & New cGMP Facility
Managed glove-box RABS build-out in ISO 5 for DP activities; led aseptic processing, EM programs, and equipment CQV through IQ/OQ/PQ.
Pilot & Commercial Operations
Custom RABS/ISO 5 with active air for roller bottle machine; UVC media treatment skid design/build; cleaning validation and BSC capabilities.
Combined project value exceeds $100M across aseptic, CQV, and facility build-out initiatives.
Stay current where science meets machines: high-throughput workcells, control systems, and data orchestration. Formal AI training and hands-on hardware/software integration keep delivery methods sharp so scientific throughput improves without sacrificing rigor.
Beyond technical execution, I care about fostering healthy, motivated teams and contributing to a culture where people feel valued and empowered. Success is built on shared values and ethical decision-making.
Commitment to rigorous science, data integrity, and compliance is non-negotiable. Every project is approached with the same dedication to quality and attention to detail that patients deserve.
At the heart of every process improvement and technical innovation is the goal of delivering life-changing treatments to patients who need them most.
BioProcess Nexus demonstrates the convergence of bioprocess engineering with lab automation and modern software. It is built for real CMC and scientific-operations challenges — showing how domain knowledge, robust hardware integration, and disciplined software design accelerate scientific delivery under GxP expectations.
Interactive planners and simulators for workcells and data pipelines, process control rooms, Monte Carlo supply forecasting, Design of Experiments, and AI-assisted regulatory intelligence — with synthetic demo data clearly labeled.
Evidence of architecting compliant, production-grade solutions for biopharma scientific operations: high-throughput workcell planning, LIMS/ELN-oriented payloads, PLC-aware control narratives, and CMC case studies on one stack.
BioProcess Nexus is my interactive portfolio — engineering tools and case studies that put real CMC and automation reasoning on screen. End-to-end spines include GLP-1 peptide TFF scale-up, a validation-forward ChAd adenoviral vaccine lifecycle, and a Digital Automation stack from lab systems through process OT and data foundation — plus an Interactive High-Throughput Workcell Planner for hiring managers and collaborators evaluating lab automation fit.
Upstream (seed → infection → harvest) and downstream (TFF/UF-DF) simulators with integrated yield, CPP windows, and a live harvest handoff.
ChAd adenoviral and GLP-1 playbooks mapped to the FDA Stage 1–3 lifecycle, FMEA risk, PPQ readiness, and CPV.
High-throughput workcell configuration, payload simulation to LIMS/ELN / data foundry paths, and multi-layer scripting hooks (Python, C#, Ladder Logic / Structured Text).
Save-to-project artifacts roll up into a milestone timeline, budget, and CQV/PPQ readiness — with a Part 11-style audit trail.
Looking for someone who bridges bioprocess scale-up with executable lab automation — workcells, control systems, and data foundry connectivity — while staying grounded in people, culture, and patient-focused innovation? Let's discuss how we can accelerate scientific delivery together.